Enzian Pharmaceutics
Phase 1It is well-known that for an optimal drug therapy the drug concentration in blood should be within a narrow, optimal range. With the present oral solid dosage forms (the tablets and capsules), however, the optimal range often cannot be attained.
Founded
2016
Focus
Drug Delivery
About
It is well-known that for an optimal drug therapy the drug concentration in blood should be within a narrow, optimal range. With the present oral solid dosage forms (the tablets and capsules), however, the optimal range often cannot be attained.
Funding History
2Total raised: $17.5M
Series A$15MUndisclosedJan 15, 2022
Seed$2.5MUndisclosedMar 15, 2020
Company Info
TypePrivate
Founded2016
LocationZug, Switzerland
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile